<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>OICC Press</PublisherName>
<JournalTitle>Progress in Biomaterials</JournalTitle>
<Issn>2194-0517</Issn>
<Volume>10</Volume>
<Issue>1 (March 2021)</Issue>
<PubDate PubStatus="epublish">
<Year>2021</Year>
<Month>03</Month>
<Day>18</Day>
</PubDate>
</Journal>
<ArticleTitle>Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies</ArticleTitle>
<VernacularTitle></VernacularTitle>
<FirstPage></FirstPage>
<LastPage></LastPage>
<ELocationID EIdType="doi">10.1007/s40204-021-00154-7</ELocationID>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Krishna</FirstName>
<LastName>Yadav</LastName>
<Affiliation>University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, Chhattisgarh, 492010, IN</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Akanksha</FirstName>
<LastName>Soni</LastName>
<Affiliation>University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, Chhattisgarh, 492010, IN</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Deependra</FirstName>
<LastName>Singh</LastName>
<Affiliation>University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, Chhattisgarh, 492010, IN</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
<Author>
<FirstName>Manju Rawat</FirstName>
<LastName>Singh</LastName>
<Affiliation>University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, Chhattisgarh, 492010, IN</Affiliation>
<Identifier Source="ORCID"></Identifier>
</Author>
</AuthorList>
<PublicationType>Journal Article</PublicationType>
<History>
<PubDate PubStatus="received">
<Year>2021</Year>
<Month>03</Month>
<Day>18</Day>
</PubDate>
</History>
<Abstract>Abstract
In recent decades, topical treatments to dermal disorders have shown ineffectiveness in delivering the medication at a particular location without a suitable drug carrier. Psoriasis treatment is hindered because of the ineffective delivery and efficacy of conventional pharmaceutical treatment. In conventional medication formulation approach, it is difficult to breach the transdermal layer of a skin membrane for topical drugs, i.e. cyclosporine, methotrexate. This problem is further complicated by extreme disease-associated conditions such as hyperkeratosis and irritation. Intending to assure better drug delivery carriers, this review emphasizes the therapeutic efficacy of polymers and their potential to deliver the drug into the deeper layer of the skin membrane. The polymers are essential in structural and physiochemical perspectives as it works as a carrier for the medication. A vast variety of delivery carriers is available nowadays but their applicability in such dermal cases like psoriasis is still lacking due to less knowledge on an appropriate polymer. The current investigation of suitable polymer would assist in brushing our expertise to optimize the advantages of a wide spectrum of polymers to fulfill the topical targeting of psoriasis.</Abstract>
<ObjectList>
<Object Type="keyword">
<Param Name="value">Psoriasis</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Hyperkeratosis</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Inflammation</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Polymeric carrier</Param>
</Object>
<Object Type="keyword">
<Param Name="value">Immune-mediated skin disorder</Param>
</Object>
</ObjectList>
</Article>
</ArticleSet>